Understanding Heart Murmurs in Adopted Dogs
When an adopted dog presents with a heart murmur, veterinarians treat it as a screening‑and‑confirmation process. The murmur signals abnormal blood flow, but it does not alone define heart failure, prognosis, or treatment needs. The critical task is to separate a benign innocent murmur from two serious conditions: myxomatous mitral valve disease (MMVD) and dilated cardiomyopathy (DCM). The distinction relies on a combination of auscultation, thoracic radiographs, echocardiography, electrocardiography, Holter monitoring, and NT‑proBNP testing.
Key Cardiac Conditions in Adopted Dogs
Innocent (Physiologic) Murmur
- Low intensity, typically grade I–II/VI.
- Systolic, localized over the left heart base.
- No associated clinical signs: normal pulse, breathing, growth, and activity.
- Often seen in puppies; can be caused temporarily by fever, anemia, excitement, or high‑flow states.
- Echocardiography shows a structurally normal heart.
Myxomatous Mitral Valve Disease (MMVD)
- Most common acquired heart disease in small‑breed, older dogs.
- Thickened, irregular mitral valve → regurgitation from left ventricle to left atrium.
- Typical left‑sided apical systolic murmur.
- Progressive left‑atrial and left‑ventricular enlargement; cough, increased resting respiratory rate, exercise intolerance once congestive heart failure (CHF) develops.
- Murmur intensity does not reliably reflect disease severity.
Dilated Cardiomyopathy (DCM)
- Primarily a myocardial disease affecting large and giant breeds (Doberman, Great Dane, Irish Wolfhound, Boxer, some retrievers and spaniels).
- Ventricular dilation with weak systolic contraction.
- May present with a soft murmur, weak pulses, exercise intolerance, fainting, or sudden death from ventricular arrhythmia.
- Diagnosis hinges on left‑ventricular dilation and reduced systolic function after excluding other causes.
- Echocardiography and 24‑hour Holter monitoring are central.
Diagnostic Toolbox: From Stethoscope to Biomarker
Auscultation – The First Triage
Auscultation evaluates murmur location, timing, grade, radiation, heart rate, rhythm, pulse quality, and additional sounds (e.g., gallop). While a systolic murmur loudest over the left apex suggests MMVD, DCM may produce a softer murmur or none at all. Auscultation alone cannot reliably differentiate early MMVD from an innocent murmur.
Thoracic Radiographs
Radiographs assess overall heart size, pulmonary vessels, edema, and other thoracic pathology. The vertebral heart size (VHS) measurement is commonly used; values >10.5 vertebrae often indicate clinically important enlargement in MMVD. Radiographs are essential for confirming CHF but cannot detect valve leakage or early structural changes.
Echocardiography – The Gold Standard
Echo visualizes valve morphology, regurgitation (Doppler), chamber dimensions, and systolic function. Key measurements for MMVD include:
- LA/Ao ratio ≥ 1.6
- LVIDDN ≥ 1.7 (normalized left‑ventricular internal diastolic diameter)
- Corresponding radiographic VHS > 10.5 (breed‑adjusted)
For DCM, echo reveals ventricular dilation and reduced fractional shortening. Echo also helps rule out congenital defects or pericardial disease.
Electrocardiography and Holter Monitoring
A standard ECG identifies persistent arrhythmias, while a 24‑hour Holter captures intermittent ventricular premature complexes, tachycardia runs, or atrial fibrillation—especially important in DCM‑prone breeds.
NT‑proBNP Testing
NT‑proBNP rises when cardiac walls stretch. It aids in distinguishing cardiac from non‑cardiac respiratory signs and can flag occult myocardial disease. Limitations include:
- Not a substitute for echo.
- Sensitivity and specificity vary by breed and disease stage.
- Renal disease, pulmonary hypertension, and body size influence results.
In Dobermans, a cutoff > 400 pmol/L showed 81 % sensitivity and 75 % specificity for any DCM stage; > 550 pmol/L improved specificity to 90 % for echocardiographic abnormalities.
Stage‑Based Treatment for MMVD
| Stage | Definition | Typical Approach |
|---|---|---|
| Stage A | At‑risk dog, no detectable structural disease | No cardiac meds; periodic screening (exam, echo, biomarkers) |
| Stage B1 | Structural disease, murmur present, no significant enlargement | Monitoring every 6–12 months; no routine pimobendan |
| Stage B2 | Structural disease with significant enlargement, no CHF signs | Start pimobendan if LA/Ao ≥ 1.6 and LVIDDN ≥ 1.7 (or equivalent VHS) |
| Stage C | Current or past CHF | Combination therapy: pimobendan, loop diuretic, spironolactone, ACE‑inhibitor as needed; monitor kidneys/electrolytes |
| Stage D | Refractory CHF despite standard therapy | Escalated diuretics, torsemide, additional vasodilators/antiarrhythmics, specialist referral, palliative planning |
Managing Dilated Cardiomyopathy
Preclinical DCM may be treated with pimobendan once echo confirms ventricular dilation and reduced systolic function. ACE inhibitors are added selectively based on blood pressure, renal function, and evidence of neurohormonal activation.
Clinical DCM (CHF or arrhythmia) often requires:
- Pimobendan
- Loop diuretics (furosemide or torsemide)
- Spironolactone
- ACE inhibitor or ARB
- Anti‑arrhythmic agents when indicated
- Oxygen and hospitalization for acute decompensation
Holter monitoring is crucial because sudden ventricular arrhythmias can cause death before overt CHF. Dietary evaluation is also essential; any changes should be guided by a veterinary nutritionist.
Exercise Guidelines for Dogs with Cardiac Disease
Innocent Murmur or Early Stable MMVD
Normal, age‑appropriate activity is generally safe. No restriction is needed solely because of a soft murmur.
Preclinical DCM
Allow regular self‑directed play, but avoid prolonged, high‑intensity exertion—especially in extreme temperatures. Limit repeated ball fetch, long swims, endurance runs, or intense Frisbee sessions.
Congestive Heart Failure or Significant Arrhythmia
Strictly avoid:
- Forced running or high‑intensity fetch
- Competitive agility, endurance work, or intense swimming
- Exercise in hot, humid, or very cold conditions
- Any activity that triggers coughing, marked fatigue, collapse, or abnormal breathing
Short, calm walks may be tolerated if the cardiologist approves. Owners should track sleeping respiratory rate; a persistent rate > 30 breaths/min or a rising trend warrants veterinary contact.
Prognosis Overview
Innocent Murmur
Excellent prognosis when echo confirms a normal heart. The murmur often resolves as the puppy matures.
MMVD
Progression varies widely:
- Many dogs stay in Stage B1 for years.
- Stage B2 dogs can remain asymptomatic for a substantial period, especially with pimobendan.
- Once CHF appears (Stage C), prognosis depends on response to therapy, kidney function, pulmonary pressure, rhythm status, and degree of valve disease.
Adverse prognostic indicators include marked left‑atrial enlargement, pulmonary hypertension, recurrent edema, renal dysfunction, arrhythmias, and a rising resting respiratory rate.
DCM
Generally more guarded than early MMVD. Survival is influenced by:
- Clinical vs. occult disease
- Severity of systolic dysfunction
- Frequency and severity of ventricular arrhythmias
- Presence of CHF
- Breed genetics and response to pimobendan
- Renal tolerance of diuretics
Breed‑specific risks (e.g., Doberman sudden death) make serial Holter monitoring essential.
2026 Veterinary Cost Snapshot (U.S.)
| Service | Approximate 2026 Cost |
|---|---|
| General veterinary examination | $60–$150 |
| Specialist cardiology consultation | $150–$300+ |
| Chest radiographs | $150–$400 |
| Electrocardiogram (ECG) | $75–$200 |
| Echocardiogram | $400–$800 |
| NT‑proBNP laboratory test | $100–$250 |
| CBC/chemistry & electrolytes | $100–$300 |
| Holter monitoring (rental & interpretation) | $300–$700 |
| Comprehensive cardiac workup | $900–$2,000 |
Leave a Reply